The Latest Cardiac and Vascular News
Eve Lee to join SIR on Jan. 27, 2025 FAIRFAX, Va., Dec. 5, 2024 /PRNewswire/ — The Society of Interventional Radiology (SIR) is pleased to announce that Eve Lee, MBA, CAE, will join the organization on Jan. 27, 2025, as its new chief executive officer. In this role, Ms. Lee will advance…
MOUNTAIN VIEW, Calif., Dec. 5, 2024 /PRNewswire/ — AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced that the company has been named 2024 Inc. Best in Business Awards winner in the Innovation and Technology category for Kardia 12L…
December 04, 2024 06:00 AM Eastern Standard Time NEW YORK–(BUSINESS WIRE)–Edwards Lifesciences Corporation (NYSE: EW) will discuss the company’s focused strategy for long-term sustainable growth, provide an update on its technology pipeline to serve more patients and share financial guidance today during its annual investor conference. Edwards enters 2025, its […]
CARLSBAD, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced a realignment of resources and operational downsizing.
December 4, 2024 (DENVER) – Today Cleerly, a leader in advanced cardiovascular imaging, announced the successful closure of its Series C extension funding round, raising a total of $106 million. This funding round was led by global software investor Insight Partners and joined by Battery Ventures with participation from pre-existing investors. With this new funding, Cleerly will continue […]
December 02, 2024 08:00 AM Eastern Standard Time SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the world leader in AI-driven medical imaging analysis and coordinated care, today announced the launch of its Rapid Enterprise™ Platform, powered by Rapid Edge Cloud. Rapid Enterprise includes the addition of the Rapid Navigator Pro™ and third-party integration. […]
Company expands clinical program beyond 70 patients already treated in South America FIH and Feasibility Studies. FDA acknowledged potential benefits of the Supira System by granting the company a review pathway under the Breakthrough Device Program. Results from EFS will be used to support submission to FDA for Supira’s pivotal […]
AUSTIN, Texas, Dec. 4, 2024 /PRNewswire/ — Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center recently became the first in the nation to use an all-in-one high-density mapping and dual energy ablation catheter for the treatment of…
– Solid Biosciences to collaborate with Mayo Clinic’s genetic cardiology disease laboratory –
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and metabolic diseases, today announced the completion of a $115 million Series D financing that included the conversion of issued convertible […]
